Published
In this exclusive interview with The Capital Compass, Dr. Pete Smith from Race Oncology discusses the company's groundbreaking work on RC220, a reformulated cancer drug with a proven history of efficacy and safety.
- Categoria
- Oncology
Commenta per primo questo video.
Prossimo
-
05:22
Alexandria Smith - A Young Family Copes with a Stage 4 Stomach Cancer
-
05:30
ESMO25 Breast Cancer Highlights: Antibody-Drug Conjugates | Dana-Farber Cancer Institute
-
05:22
HRH Princess Dina Mired joins OncoThon 2025 to Support Pediatric Cancer Research
-
04:11
The Cancer Center at UM Capital Region Health provides complete cancer care for Prince George’s Coun
-
07:35
Executive Class: Vital organ screening & cancer detection at Healthway Cancer Care Hospital | ANC
-
14:52
Was Marriage Between Jada and Will Smith a Sham? | Jada Pinkett Smith Marriage Revelation Analysis
-
16:23
CANCER BREAKTHROUGH: Moderna, Merck report cancer discovery
-
07:02
Lung Cancer Screening: Multidisciplinary Experts Discuss Barriers, Opportunities
-
18:52
Lantern Pharma Uses AI to Transform Cancer Drug Development | Breakthrough Trials & ZETA Platform
-
04:46
Dr James Garner on Percheron Therapeutics' breakthrough breast cancer drug data
-
09:07
Cardiology for Beginners: Basics of Heart Sounds and Murmurs (with examples)
-
13:45
How to Become a Cardiologist | Cardiac Electrophysiologist
-
04:14
V 00592 Cardiology Fellowship Video Dr Vranian V5
-
05:17
Cardiology Fellowship at SIU Medicine
-
04:15
Cardiology Fellowship Program at Danbury Hospital
-
05:49
Practice Question: Cardiology #1, USMLE Step 1, COMLEX Level 1
-
04:07
Dr. Muhammed Raza on advice for Fellows interested in Interventional Cardiology
-
07:36
Congenital Heart Disease – Cardiology | Lecturio
-
05:18
Cardiology Fellowship at IU School of Medicine
-
04:36
What are different types of Cardiology Tests | SPS Hospitals
